Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Mass Spectrometry Helps Fight Bioterror Agents

By HospiMedica staff writers
Posted on 13 Sep 2006
A quick, cost-effective way has been developed to screen and identify bioterror agents and other substances used in hoax incidents.

Researchers at the U.S. More...
Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR-FDA, Jefferson, AR, USA) have developed a testing method for bioterror agents using mass spectrometry. This technique identifies and quantifies compounds, based on the structure and chemical properties of their molecules, quickly and with a very high degree of accuracy. Researchers can take patterns generated by a mass spectrometer's analysis of a substance that needs to be identified and compare them to a database of known substances, permitting immediate recognition, in a process similar to fingerprint matching. The new technique is very fast, taking about seven minutes for each sample on the mass spectrometer.

The NCTR has examined the mass spectrometric fingerprints of a variety of chemical and biologic materials that could be used in a biologic attack. These include two types of food poisoning bacteria, Vibrio parahaemolyticus (associated with illness from eating oysters), and Salmonella enterica, (a bacteria often found in poultry that causes gastrointestinal illness). Other inert substances, such as flour and corn starch have also been fingerprinted. The testing method could be used to distinguish samples of all sorts, addressing the analytic needs of the food industry, law enforcement, and military authorities as well as regulatory agencies. The study was published in the August 30, 2006, edition of the journal Rapid Communications in Mass Spectrometry

"Our new technique, along with fingerprinting, offers a rapid and valuable assessment of a range of bioterror and hoax samples,” said NCTR's Dr. Jon Wilkes, Ph.D., the lead author of the study. "We hope to see the testing put into place by government and industry in the near future. Anytime we can run tests more quickly, we can benefit public health and safety.”



Related Links:
National Center for Toxicological Research

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.